Lucia, F., MIEVIS, C., Jansen, N., Duysinx, B., Cousin, F., LOUIS, T., BAIWIR, M., ERNST, C., WONNER, M., Hustinx, R., Lovinfosse, P.* , & Coucke, P.*. (2024). Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience. Clinical and Translational Radiation Oncology, 100720. doi:10.1016/j.ctro.2023.100720 Peer Reviewed verified by ORBi * These authors have contributed equally to this work. |
Colin, G., Ben Mustapha, S., Jansen, N., Coucke, P., Seidel, L., Berkovic, P., & Janvary, L. (March 2023). Interval From Simulation Imaging to Treatment Delivery in SABR of Lung Lesions: How Long is Too Long for the Lung? Advances in Radiation Oncology, 8 (2), 101132. doi:10.1016/j.adro.2022.101132 Peer Reviewed verified by ORBi |
Vaandering, A., Jansen, N., Weltens, C., Moretti, L., Stellamans, K., Vanhoutte, F., Scalliet, P., Remouchamps, V., Lievens, Y., & Belgian College for Physicians in Radiation Oncology. (January 2023). Radiotherapy-specific quality indicators at national level: How to make it happen. Radiotherapy and Oncology, 178, 109433. doi:10.1016/j.radonc.2022.11.022 Peer Reviewed verified by ORBi |
Lucia, F., LOUIS, T., Cousin, F., Bourbonne, V., Visvikis, D., MIEVIS, C., Jansen, N., Duysinx, B., Le Pennec, R., Nebbache, M., Rehn, M., Hamya, M., Geier, M., Salaun, P.-Y., Schick, U., Hatt, M., Coucke, P., Hustinx, R., & Lovinfosse, P. (2023). Multicentric development and evaluation of [ 18 F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06510-y Peer Reviewed verified by ORBi |
BEN MUSTAPHA, S., Simoni, P., DUBOIS, N., JANSEN, N., Lakosi, F., Silva Mota, A., Ramella, S., & COUCKE, P. (March 2022). The COVID-19 Status of Patients Is an Essential Determinant for Decision-Making by Radiation Oncologists: A European Survey. Cureus, 14 (3), 22842. doi:10.7759/cureus.22842 Peer reviewed |
Ghassan, H., Jansen, N., & Coucke, P. (August 2021). PO-1052 Cyberknife stereotactic radiotherapy for vestibular schwannomas :a single institution experience. Radiotherapy and Oncology, 161, 876. doi:10.1016/s0167-8140(21)07503-4 Peer Reviewed verified by ORBi |
Berkovic, P., GULYBAN, A., Defraene, G., Swenen, L., Dechambre, D., NGUYEN, P. V., Jansen, N., MIEVIS, C., LOVINFOSSE, P., Janvary, L., Lambrecht, M., & De Meerleer, G. (2020). Stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases. BMC Cancer, 20 (1), 402. doi:10.1186/s12885-020-06906-1 Peer Reviewed verified by ORBi |
Etienne, A.-M., Gamin, N., JANSEN, N., Coucke, P., & Simon, J. (20 May 2019). Vidéo virtuelle, radiothérapie stéréotaxique et diminution de l’anxiété : quel enjeu pour le patient ? [Poster presentation]. La qualité de vie au coeur des soins de première ligne : Evaluations, applications et persepctives, Liège, Belgium. |
Gamin, N., JANSEN, N., COUCKE, P., Etienne, A.-M., & Simon, J. (14 May 2019). Virtual reality: A tool in the treatment of anxiety in stereotaxic radiotherapy? [Poster presentation]. BAPS, Liège, Belgium. |
BEN MUSTAPHA, S., Meijnders, P., COUCKE, P., JANSEN, N., & lakosi, F. (2019). The status of radiation oncology (RO) teaching to medical students in Europe. Clinical and Translational Radiation Oncology. doi:10.1016/j.ctro.2019.04.010 Peer Reviewed verified by ORBi |
Wink, K., Roelofs, E., Ii, C., Dechambre, D., Santiago, A., Van Der Stoep, J., Dries, W., Smits, J., Avery, S., Ammazzalorso, F., Jansen, N., Jelen, U., Solberg, T., De Ruysscher, D., & Troost, E. (12 March 2018). Photons, protons or carbon ions for stage I non-small cell lung cancer -Results of the multicentric ROCOCO in silico study. Radiotherapy and Oncology, 128 (1), 139-146. doi:10.1016/j.radonc.2018.02.024 Peer Reviewed verified by ORBi |
Dechambre, D., Janvary, L. Z., Jansen, N., Berkovic, P., MIEVIS, C., Baart, V., CUCCHIARO, S., Coucke, P., & Gulyban, A. (January 2018). Prediction of GTV median dose differences eases Monte Carlo re-prescription in lung SBRT. Physica Medica, 45, 88-92. doi:10.1016/j.ejmp.2017.12.002 Peer Reviewed verified by ORBi |
BEGUIN, C., Jansen, N., & LOLY, C. (2018). Metastase atypique d'un cancer colo-rectal : le pont est mine ! Revue Médicale de Liège, 73 (7-8), 419-424. Peer reviewed |
Berkovic, P., GULYBAN, A., Nguyen, P. V., DECHAMBRE, D., Martinive, P., JANSEN, N., Lakosi, F., Janvary, L., & Coucke, P. (20 March 2017). Stereotactic Robotic Body Radiotherapy for Patients With Unresectable Hepatic Oligorecurrence. Clinical Colorectal Cancer, 16 (4), 349-357.e1. doi:10.1016/j.clcc.2017.03.006 Peer Reviewed verified by ORBi |
Dechambre, D., Baart, V., CUCCHIARO, S., ERNST, C., Jansen, N., Berkovic, P., MIEVIS, C., Coucke, P., & Gulyban, A. (January 2017). Commissioning Monte Carlo algorithm for robotic radiosurgery using cylindrical 3D-array with variable density inserts. Physica Medica, 33, 152-158. doi:10.1016/j.ejmp.2017.01.005 Peer Reviewed verified by ORBi |
Janvary, Z. L., JANSEN, N., BAART, V., DEVILLERS, M., DECHAMBRE, D., LENAERTS, E., SEIDEL, L., BARTHELEMY, N., BERKOVIC, P., GULYBAN, A., lakosi, F., zsolt, H., & COUCKE, P. (2017). Clinical outcomes of 130 patients with primary and secondary lung tumors treated with Cyberknife robotic stereotactic body radiotherapy. Radiology and Oncology, 51 (2), 178-186. doi:10.1515/raon-2017-0015 Peer Reviewed verified by ORBi |
LOVINFOSSE, P., Janvary, Z. L., COUCKE, P., JODOGNE, S., BERNARD, C., Hatt, M., Visvikis, D., JANSEN, N., DUYSINX, B., & HUSTINX, R. (2016). FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-016-3314-8 Peer Reviewed verified by ORBi |
LAKOSI, F., DE CUYPERE, M., NGUYEN, V. P., JANSEN, N., WARLIMONT, B., GULYBAN, A., GENNIGENS, C., SEIDEL, L., DELBECQUE, K., COUCKE, P., HERMESSE, J., & KRIDELKA, F. (2015). Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients : a mono-institutional experience. Acta Oncologica, 54 (9), 1558-1566. doi:10.3109/0284186X.2015.1062542 Peer Reviewed verified by ORBi |
COUCKE, P., JANVARY, Z. L., & JANSEN, N. (2014). L’INTÉRÊT DE LA RADIOTHÉRAPIE «ABLATIVE» EN PRENANT COMME MODÈLE LA MÉTASTASE D’UN CANCER RÉNAL À CELLULES CLAIRES. Revue Médicale de Liège, 69 (Supp 1), 94-100. Peer reviewed |
JANVARY, Z. L., JANSEN, N., & COUCKE, P. (2014). LE CYBERKNIFE AIME LES DEFIS ! Aperçu d'indications pour la radiothérapie extracrânienne robotisée. Revue Médicale de Liège, 69 (Supp 1), 87-93. Peer reviewed |
LOVINFOSSE, P., JANVARY, Z. L., JANSEN, N., DISTER, F., FRUSCH, N., DUYSINX, B., COUCKE, P., & HUSTINX, R. (2013). Prognostic value of FDG PET/CT in patients with lung tumors treated by Cyberknife. Journal of Nuclear Medicine, 54 (SUPPL), 567. Peer Reviewed verified by ORBi |
JANSEN, N. (26 April 2012). Reimbursement of radiotherapy in Belgium [Paper presentation]. Benelux User Meeting, Scheveningen, Netherlands. |
JANSEN, N. (2012). Le futur centre intégré d'oncologie de Liège (CIO) : analyse des besoins de l'équipe de radiothérapie-oncologie. L'application des principes de 'healing environment'. |
JANSEN, N., SOBCZAK, S., RUYANGE, B. W., & CHOUFFART, L. (2012). La radiothérapie des cancers urologiques : cours d'introduction pour l'ensemble des intervénants médicaux et non-médicaux. (ULiège - Université de Liège). |
BARTHELEMY, N., JANSEN, N., GENNIGENS, C., DELGAUDINE, M., & COUCKE, P. (2012). y a-t-il une place pour la radiothérapie en fin de vie ? Revue Médicale de Liège, 67 (3), 128/132. Peer reviewed |
LALLEMAND, F., JANVARY, Z. L., JANSEN, N., & COUCKE, P. (November 2011). Cyberknife et pathologies bénignes. Revue Médicale de Liège, 66 (11), 568-574. Peer reviewed |
JANSEN, N., & COUCKE, P. (15 October 2011). Cyberknife for lung tumors : the first Belgian experience at CHU Liege and initiated research projects [Paper presentation]. AERO meeting 2011, Istanbul, Turkey. |
JANSEN, N. (29 April 2011). Stereotactic Cyberknife based radiotherapy: introduction and possible dosimetric comparisons with other treatment techniques [Paper presentation]. Radiotherapy meeting, Brussels, Belgium. |
COUCKE, P., JANSEN, N., JANVARY, Z. L., LOUIS, C., VANDERICK, J., RORIVE, A., COLLIGNON, J., LIFRANGE, E., MAWEJA, S., & JERUSALEM, G. (2011). Accelerated partial breast irradiation: state of the art. Belgian Journal of Medical Oncology, 5 (1), 3-7. Peer Reviewed verified by ORBi |
DELGAUDINE, M., LENAERTS, E., JANSEN, N., & COUCKE, P. (2011). Implementation of an Experience feed back committee (EFBC) and impact on prevention and risk management in radiotherapy [Poster presentation]. ASQUA. |
COUCKE, P., JANVARY, Z. L., BAART, V., DEVILLERS, M., JANSEN, N., & LENAERTS, E. (2011). Ai-je bien entendu ? Je peux me faire traiter autrement que par chirurgie pour mon schwannome de l’acoustique. Revue Médicale de Liège, 66 (10), 521-528. Peer reviewed |
COUCKE, P., LAKOSI, F., RORIVE, A., JANVARY, Z. L., COLLIGNON, J., JANSEN, N., ANDRE, C., & JERUSALEM, G. (2011). Radiothérapie et cancer du sein : "standards" de traitement, prédiction de rechute locale et questions ouvertes. Revue Médicale de Liège, 66 (5-6), 320-325. Peer reviewed |
Jansen, F. H., Adoubi, I., Kouassi, C. J. C., De Cnodder, T., JANSEN, N., Tschulakow, A., & Efferth, T. (2011). First study of oral artenimol-R in advanced cervical cancer: clinical benefit, tolerability and tumor markers. Anticancer Research, 31 (12), 4417-4422. Peer Reviewed verified by ORBi |
JANVARY, Z. L., JANSEN, N., MARTINIVE, P., & COUCKE, P. (2011). New indications for radiotherapy: primary liver cancer and secondary liver oligometastases. Belgian Journal of Medical Oncology, 5 (1), 8-13. Peer Reviewed verified by ORBi |
JANVARY, Z. L., JANSEN, N., MATHOT, M., LENAERTS, E., MARTINIVE, P., & COUCKE, P. (September 2010). EVALUATION OF THE AUTOMATIC IMAGE REGISTRATION FEATURES OF A KV CONE-BEAM CT IMAGING SYSTEM [Poster presentation]. Congrès. |
JANVARY, Z. L., JANSEN, N., MATHOT, M., LENAERTS, E., MARTINIVE, P., & COUCKE, P. (September 2010). EVALUATION OF THE AUTOMATIC IMAGE REGISTRATION FEATURES OF A KV CONE-BEAM CT IMAGING SYSTEM. Radiotherapy and Oncology, 96 (supp 1). Peer Reviewed verified by ORBi |
DELGAUDINE, M., JANSEN, N., & COUCKE, P. (September 2010). Experience feed back committee (EFBC) in radiotherapy [Poster presentation]. ESTRO. |
COUCKE, P., WITHOFS, N., JANSEN, N., JANVARY, Z. L., & HUSTINX, R. (2010). Vers une radiothérapie chirurgicale :nécessité d’une radiothérapie guidée par l’imagerie. Revue Médicale de Liège, 65 (supp 1), 17-22. Peer reviewed |
Coucke, P., Jansen, N., Collignon, J., Janvary, Z. L., Rorive, A., Vanderick, J., & Jerusalem, G. (January 2010). Pourquoi les traitements de radiothérapie adjuvante pour cancer du sein ne comptent-ils plus autant de séances ? Revue Médicale de Liège, 65 (1), 10-14. Peer reviewed |
Hermesse, J., Biver, S., JANSEN, N., LENAERTS, E., De Patoul, N., Vynckier, S., COUCKE, P., Scalliet, P., & Nickers, P. (2009). A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy. Strahlentherapie und Onkologie, 185 (11), 736-742. doi:10.1007/s00066-009-2009-5 Peer Reviewed verified by ORBi |
Mievis, C., Jansen, N., Schleich, F., Gennigens, C., Rorive, A., Jerusalem, G., Fillet, G., & Sautois, B. (2009). Le cas clinique du mois. Reaction de rappel d'irradiation induite par l'administration de cyclophosphamide. Revue Médicale de Liège, 64 (4), 179-81. Peer reviewed |
Coucke, P., Barthelemy, N., Jansen, N., Trivière, N., & Jerusalem, G. (February 2008). Carcinome intracanalaire (in situ) du sein : pouvons-nous raisonnablement éviter la radiothérapie pour certaines patientes opérées ? Revue Médicale de Liège, 63 (2), 75-81. Peer reviewed |
Coucke, P., Barthelemy, N., Jansen, N. (Other coll.), Triviere, N. (Other coll.), & Jerusalem, G. (Other coll.). (2008). Carcinome intracanalaire (in situ) du sein : pouvons-nous raisonnablement éviter les radiothérapie pour certaines patientes opérées? Revue Médicale de Liège, 63 (2), 75-81. Peer reviewed |
Hermesse, J., Thissen, B., Warlimont, B., Jansen, N., Coucke, P., & Niockers, P. (2008). Analysis of Dose Volume Histogram Differences between High Dose Rate Brachytherapy and Intensity Modulated Radiotherapy for Prostate Treatment. International Journal of Radiation, Oncology, Biology, Physics, 72 (1 (supplément)), 566. doi:10.1016/j.ijrobp.2008.06.140 Peer Reviewed verified by ORBi |
Jansen, N., Deneufbourg, J.-M., & Nickers, P. (15 March 2007). Adjuvant stereotactic permanent seed breast implant: A boost series in view of partial breast irradiation. International Journal of Radiation, Oncology, Biology, Physics, 67 (4), 1052-1058. doi:10.1016/j.ijrobp.2006.10.031 Peer Reviewed verified by ORBi |
Jansen, N., & Nickers, P. (October 2006). A new technique of stereotactic permanent breast seed implantation. Radiotherapy and Oncology, 81 (Suppl. 1), 249-S250. Peer Reviewed verified by ORBi |
Meyns, M., Jansen, N., & Deneufbourg, J.-M. (September 2006). Place de la radiotherapie dans le traitement du cancer du sein. Indications actuelles et perspectives. Revue Médicale de Liège, 61 (9), 623-31. Peer reviewed |
Nickers, P., Coppens, L., De Leval, J., Jansen, N., & Deneufbourg, J.-M. (June 2006). 192ir Low Dose Rate Brachytherapy for Boosting Locally Advanced Prostate Cancers after External Beam Radiotherapy: A Phase Ii Trial. Radiotherapy and Oncology, 79 (3), 329-34. doi:10.1016/j.radonc.2006.05.013 Peer Reviewed verified by ORBi |
Jansen, N., Nickers, P., & Deneufbourg, J.-M. (February 2006). L'irradiation partielle du sein et le role de la curietherapie: une nouvelle approche therapeutique pour les carcinomes mammaires de bon pronostic. Revue Médicale de Liège, 61 (2), 97-103. Peer reviewed |
Nickers, P., Thissen, B., Jansen, N., & Deneufbourg, J.-M. (January 2006). 192-Ir or 125-I Prostate Brachytherapy as a Boost to External Beam Radiotherapy in Locally Advanced Prostatic Cancer: A Dosimetric Point of View. Radiotherapy and Oncology, 78 (1), 47-52. doi:10.1016/j.radonc.2005.09.002 Peer Reviewed verified by ORBi |
Nickers, P., Thissen, B., Jansen, N., & Deneufbourg, J.-M. (October 2004). 192lr LDR brachytherapy(BT) is at least as efficient as HDR options for boosting unfavourable prostate cancers after EBRT. Proposals for future prospects. Radiotherapy and Oncology, 73 (Suppl. 1), 83. Peer Reviewed verified by ORBi |
Nickers, P., Jansen, N., Thissen, B., & Deneufbourg, J.-M. (May 2004). 192Ir LDR Brachytherapy(BT) is at least as efficient as HDR options for boosting intermediate or unfavourable prostate cancers after EBRT. Experience on 201 patients. Radiotherapy and Oncology, 71 (Suppl. 2), 124-S125. Peer Reviewed verified by ORBi |
Jansen, N. (2004). Radiothérapie - Une explication pas à pas de l'irradiation. Kessel-Lo, Belgium: Garant. |
Jansen, N. (2001). Radiotherapie - Stap-voor-stap uitleg over bestraling. Kessel-Lo, Belgium: Garant. |
Jansen, N. (2000). Radiotherapie - Stap-voor-stap uitleg over bestraling. Kessel-Lo, Belgium: Garant. |
Jansen, N., Nickers, P., & Devoghel, J.-C. (2000). La douleur pelvienne chez le patient oncologique. Oncologie, 2 (4), 187-200. Peer Reviewed verified by ORBi |